15-Bio ApS: Financial statements 2023
CVR: 39889277
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
15-Bio ApS (CVR 39889277) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -5,001 and a net result of DKK -5,001 compared with DKK -3,577 the year before. Equity in the 2023 report amounted to DKK 26,548. The solvency ratio was 59.2%.
- Gross Profit
- DKK -5,001
- Profit/Loss
- DKK -5,001
- Equity
- DKK 26,548
- Total Assets
- DKK 44,831
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -5 t. | -5 t. | 27 t. | - |
| 2022 | - | -5 t. | -4 t. | 32 t. | - |
| 2021 | - | -6 t. | -7 t. | 35 t. | - |
| 2020 | - | -1 t. | -1 t. | 42 t. | - |
| 2019 | - | -13 t. | -22 t. | 43 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
15-Bio ApS has published its annual report for 2022. Gross profit came to DKK -5,169, and the net result was DKK -3,577.
About 15-Bio ApS
15-Bio ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Rasmus Jorgensen Holdings ApS and Rasmus Jorgensen IVS. The management consists of Rasmus Jørgensen. The company is owned by Rasmus Jørgensen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity in the 2025 report amounted to DKK 11,547.